BNP Paribas Health Cr Innovtr Cl Cap
Sammenlign
Dette fondet
Tidsserie
Konsentrasjon
Type
Bransjefond
Bærekraft
Beskrivelse
This sub-fund increases the value of its assets over the medium term by investing in healthcare innovative companies. At all times, this sub-fund invests at least 75% of its assets in equities and/or equity equivalent securities issued worldwide by health care companies that enable or benefit from innovative technologies, including, but not limited to, advances in genetic sequencing, drug delivery, miniaturization, bio-compatible materials, haptics and information technology to the healthcare field. The remaining portion, namely a maximum of 25% of its assets, may be invested in any other transferable securities, money market instruments, or cash, provided that investments in debt securities of any kind do not exceed 15% of its assets, and up to 10% of its assets may be invested in UCITS or UCIs.
Avkastning
Siste 30 dager
1.32%
Siste 6 måneder
-1.76%
Hittil i år
-3.60%
Siste år
8.37%
Siste 3 år (Per år)
14.12%
Siste 5 år (Per år)
10.64%
Pris
Vis priser med rabatt for
Akademikerne Pluss
Er du ikke medlem? Meld deg inn her
Pris for fondet
1.98%
Plattformavgift
0.25%
Returprovisjon
0.75%
Totalpris
(Det du betaler årlig)
1.48%
Nøkkelinformasjon
Risiko
6 av 7
Morningstar-rating
3 av 5
Gyldig for aksjesparekonto
Ja
Tilgjengelig for pensjon
Nei
Aksjer
98.26%
Kontanter
1.74%
Selskaper med størst posisjon
- UNITEDHEALTH GROUP INC9.67%
- ASTRAZENECA PLC6.79%
- ELI LILLY6.54%
- BRISTOL MYERS SQUIBB6.09%
- ROCHE HOLDING PAR AG4.46%
- BOSTON SCIENTIFIC CORP3.95%
- JAZZ PHARMACEUTICALS PLC3.94%
- HORIZON THERAPEUTICS PUBLIC PLC3.39%
- THERMO FISHER SCIENTIFIC INC3.38%
- CENTENE CORP3.25%
Sektorer
- Helse99.23%
- Industri0.77%
Regioner
- Nord-Amerika76.92%
- Europa17.97%
- Asia2.57%
- Norden2.54%
- Latin-Amerika0%
- Afrika/Midt-Østen0%